Cargando…

Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury

The pathogenesis of acute liver failure (ALF) involves cell death. Necroptosis is a newly suggested programmed cell death, and receptor-interacting protein kinase 3 (RIPK3) has been reported as a marker for necroptosis. However, there are few reports on necroptosis in ALF. Therefore, we evaluated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Takayuki, Fujimoto, Kentaro, Fujiwara, Kisako, Yumita, Sae, Ishino, Takamasa, Ogawa, Keita, Nakagawa, Miyuki, Iwanaga, Terunao, Koroki, Keisuke, Kanzaki, Hiroaki, Inoue, Masanori, Kobayashi, Kazufumi, Kiyono, Soichiro, Nakamura, Masato, Kanogawa, Naoya, Ogasawara, Sadahisa, Nakamoto, Shingo, Chiba, Tetsuhiro, Kato, Jun, Fujiwara, Keiichi, Kato, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462689/
https://www.ncbi.nlm.nih.gov/pubmed/37640752
http://dx.doi.org/10.1038/s41598-023-41425-6
_version_ 1785098086593331200
author Kondo, Takayuki
Fujimoto, Kentaro
Fujiwara, Kisako
Yumita, Sae
Ishino, Takamasa
Ogawa, Keita
Nakagawa, Miyuki
Iwanaga, Terunao
Koroki, Keisuke
Kanzaki, Hiroaki
Inoue, Masanori
Kobayashi, Kazufumi
Kiyono, Soichiro
Nakamura, Masato
Kanogawa, Naoya
Ogasawara, Sadahisa
Nakamoto, Shingo
Chiba, Tetsuhiro
Kato, Jun
Fujiwara, Keiichi
Kato, Naoya
author_facet Kondo, Takayuki
Fujimoto, Kentaro
Fujiwara, Kisako
Yumita, Sae
Ishino, Takamasa
Ogawa, Keita
Nakagawa, Miyuki
Iwanaga, Terunao
Koroki, Keisuke
Kanzaki, Hiroaki
Inoue, Masanori
Kobayashi, Kazufumi
Kiyono, Soichiro
Nakamura, Masato
Kanogawa, Naoya
Ogasawara, Sadahisa
Nakamoto, Shingo
Chiba, Tetsuhiro
Kato, Jun
Fujiwara, Keiichi
Kato, Naoya
author_sort Kondo, Takayuki
collection PubMed
description The pathogenesis of acute liver failure (ALF) involves cell death. Necroptosis is a newly suggested programmed cell death, and receptor-interacting protein kinase 3 (RIPK3) has been reported as a marker for necroptosis. However, there are few reports on necroptosis in ALF. Therefore, we evaluated the role of cell death markers such as cytokeratin (CK) 18, cleaved CK (cCK) 18, and RIPK3 in ALF, as well as cytokines and hepatocyte growth factor (HGF). Seventy-one hospitalized patients with acute liver injury (38 nonsevere hepatitis [non-SH]/22 severe hepatitis [SH]/11 ALF) were studied. No significant difference was found for cytokines, but a substantial increase in HGF levels was found following the severity of hepatitis. The non-SH group had lower levels of CK18 and cCK18 than the SH/ALF group. RIPK3 was significantly lower in the non-SH/SH group than in the ALF group. HGF, RIPK3, and albumin levels were found to be important predictive variables. The present study suggests that cCK18, CK18, and RIPK3 are associated with the severity of hepatitis. RIPK3 and other markers related cell death may be useful for understanding the pathogenesis of ALF and as a prognostic marker of acute liver injury.
format Online
Article
Text
id pubmed-10462689
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-104626892023-08-30 Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury Kondo, Takayuki Fujimoto, Kentaro Fujiwara, Kisako Yumita, Sae Ishino, Takamasa Ogawa, Keita Nakagawa, Miyuki Iwanaga, Terunao Koroki, Keisuke Kanzaki, Hiroaki Inoue, Masanori Kobayashi, Kazufumi Kiyono, Soichiro Nakamura, Masato Kanogawa, Naoya Ogasawara, Sadahisa Nakamoto, Shingo Chiba, Tetsuhiro Kato, Jun Fujiwara, Keiichi Kato, Naoya Sci Rep Article The pathogenesis of acute liver failure (ALF) involves cell death. Necroptosis is a newly suggested programmed cell death, and receptor-interacting protein kinase 3 (RIPK3) has been reported as a marker for necroptosis. However, there are few reports on necroptosis in ALF. Therefore, we evaluated the role of cell death markers such as cytokeratin (CK) 18, cleaved CK (cCK) 18, and RIPK3 in ALF, as well as cytokines and hepatocyte growth factor (HGF). Seventy-one hospitalized patients with acute liver injury (38 nonsevere hepatitis [non-SH]/22 severe hepatitis [SH]/11 ALF) were studied. No significant difference was found for cytokines, but a substantial increase in HGF levels was found following the severity of hepatitis. The non-SH group had lower levels of CK18 and cCK18 than the SH/ALF group. RIPK3 was significantly lower in the non-SH/SH group than in the ALF group. HGF, RIPK3, and albumin levels were found to be important predictive variables. The present study suggests that cCK18, CK18, and RIPK3 are associated with the severity of hepatitis. RIPK3 and other markers related cell death may be useful for understanding the pathogenesis of ALF and as a prognostic marker of acute liver injury. Nature Publishing Group UK 2023-08-28 /pmc/articles/PMC10462689/ /pubmed/37640752 http://dx.doi.org/10.1038/s41598-023-41425-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kondo, Takayuki
Fujimoto, Kentaro
Fujiwara, Kisako
Yumita, Sae
Ishino, Takamasa
Ogawa, Keita
Nakagawa, Miyuki
Iwanaga, Terunao
Koroki, Keisuke
Kanzaki, Hiroaki
Inoue, Masanori
Kobayashi, Kazufumi
Kiyono, Soichiro
Nakamura, Masato
Kanogawa, Naoya
Ogasawara, Sadahisa
Nakamoto, Shingo
Chiba, Tetsuhiro
Kato, Jun
Fujiwara, Keiichi
Kato, Naoya
Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury
title Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury
title_full Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury
title_fullStr Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury
title_full_unstemmed Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury
title_short Potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury
title_sort potential of circulating receptor-interacting protein kinase 3 levels as a marker of acute liver injury
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462689/
https://www.ncbi.nlm.nih.gov/pubmed/37640752
http://dx.doi.org/10.1038/s41598-023-41425-6
work_keys_str_mv AT kondotakayuki potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT fujimotokentaro potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT fujiwarakisako potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT yumitasae potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT ishinotakamasa potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT ogawakeita potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT nakagawamiyuki potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT iwanagaterunao potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT korokikeisuke potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT kanzakihiroaki potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT inouemasanori potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT kobayashikazufumi potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT kiyonosoichiro potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT nakamuramasato potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT kanogawanaoya potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT ogasawarasadahisa potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT nakamotoshingo potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT chibatetsuhiro potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT katojun potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT fujiwarakeiichi potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury
AT katonaoya potentialofcirculatingreceptorinteractingproteinkinase3levelsasamarkerofacuteliverinjury